Medical devices

Global Gas Sensors Market and the Affects of the Coronavirus to 2021 - Featuring MSA, Amphenol & Figaro Among Others - ResearchAndMarkets.com

Tuesday, June 2, 2020 - 1:50pm

Medical & healthcare segment estimated to be the fastest-growing end-use industry for gas sensors during the forecast period.

Key Points: 
  • Medical & healthcare segment estimated to be the fastest-growing end-use industry for gas sensors during the forecast period.
  • The medical & healthcare segment is projected to grow at the fastest pace in the gas sensors market during this COVID-19 scenario.
  • The electrochemical gas sensing technology segment is projected to lead the gas sensors market during the forecast period.
  • The electrochemical gas sensing technology segment is expected to lead the gas sensors industry during the forecast period.

Medical Wearables Market by Device, Product & End-user - Global Forecast to 2025 - ResearchAndMarkets.com

Tuesday, June 2, 2020 - 1:14pm

The global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4% during the forecast period of 2020 to 2025.

Key Points: 
  • The global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4% during the forecast period of 2020 to 2025.
  • Based on device type, the vital signs monitoring segment accounted for the largest share of the market in 2019.
  • These wearables are playing an integral role in treating and monitoring various medical conditions in patients and driving better health outcomes.
  • In 2019, North America dominated the clinical-grade wearables market, followed by Europe, the Asia Pacific,
    Latin America, and the Middle East & Africa.

DeltaTrak’s Cold Chain Restart Program Helps Companies Access Critical PPE Solutions

Tuesday, June 2, 2020 - 1:00pm

DeltaTrak, a leading innovator of cold chain management and temperature monitoring solutions, is excited to announce the Cold Chain Restart Program designed to help companies reopen on a safe footing by providing access to critically needed PPE solutions.

Key Points: 
  • DeltaTrak, a leading innovator of cold chain management and temperature monitoring solutions, is excited to announce the Cold Chain Restart Program designed to help companies reopen on a safe footing by providing access to critically needed PPE solutions.
  • The Cold Chain Restart Program is aimed at assisting our customers to get back to business in the new norm, as they implement new COVID-19 protection plans.
  • The program also offers access to free facial masks when combined with our cold chain solutions.
  • DeltaTrak is a leading innovator of cold chain management, environmental monitoring and food safety solutions.

Paragonix Technologies Announces Enrollment Milestone for its Global Registry for Donor Heart Preservation

Tuesday, June 2, 2020 - 1:00pm

Paragonix Technologies, Inc. today announced that its clinical global registry, the Global Utilization And Registry Database for Improved Heart Preservation (GUARDIAN) , has reached enrollment of over 100 patients that have received a donor heart.

Key Points: 
  • Paragonix Technologies, Inc. today announced that its clinical global registry, the Global Utilization And Registry Database for Improved Heart Preservation (GUARDIAN) , has reached enrollment of over 100 patients that have received a donor heart.
  • GUARDIAN , a registered clinical trial, is open to all heart transplant centers who are looking to analyze patient outcomes based on donor heart preservation methods.
  • Paragonix Technologies markets organ transportation devices that safeguard organs during the journey between donor and recipient patients.
  • Paragonix SherpaPak CTS is the only commercially available FDA cleared and CE marked transport device for heart transportation.

Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data

Tuesday, June 2, 2020 - 12:30pm

Novocure (NASDAQ: NVCR) today announced the launch of MyLink, a new tool that allows patients to download their Optune usage data from the comfort of home without the need for an in-person visit by a Novocure Device Support Specialist.

Key Points: 
  • Novocure (NASDAQ: NVCR) today announced the launch of MyLink, a new tool that allows patients to download their Optune usage data from the comfort of home without the need for an in-person visit by a Novocure Device Support Specialist.
  • Novocure prioritized and accelerated the MyLink launch in response to recent U.S. FDA guidance supporting the expansion of remote patient monitoring.
  • MyLink is an important tool that provides a convenient way for patients to upload usage data.
  • Early and ongoing monitoring of usage data coupled with effective patient counseling may drive increased average usage and improve patient outcomes.

HemaCare Adds GMPrimeTM Cryopreserved Leukopak to its GMP Product Portfolio

Tuesday, June 2, 2020 - 1:00pm

The GMP-compliant cryopreserved leukopak includes a quality assurance (QA)-reviewed Certificate of Analysis, thus adding QA review to HemaCares popular research use (HemaPrimeTM) cryopreserved leukopak.

Key Points: 
  • The GMP-compliant cryopreserved leukopak includes a quality assurance (QA)-reviewed Certificate of Analysis, thus adding QA review to HemaCares popular research use (HemaPrimeTM) cryopreserved leukopak.
  • HemaCares GMPrime leukopaks are cryopreserved following a proprietary cryopreservation process and meet the requirements of the most rigorous quality standards required by regulatory agencies.
  • The launch of HemaCares GMPrime cryopreserved leukopak ensures the industry experiences a flexible and seamless transition as they move their therapy from research to commercialization.
  • GMPrime cryopreserved leukopaks are collected within HemaCares FDA-registered collection center from IRB-consented donors and immediately cryopreserved onsite within Class A and B (ISO 5 and 6) cleanroom environments.

SETi to Start Online Sales for Surface Disinfection Device and Portable Air Purifier with Violeds Technology to Enable Disinfection of New Coronavirus

Tuesday, June 2, 2020 - 11:09am

The online sales of the products will be started in both of South Korea and the United States from June 8th in consecutive order.

Key Points: 
  • The online sales of the products will be started in both of South Korea and the United States from June 8th in consecutive order.
  • When using the mask repeatedly, there is a high risk of the virus passing through the mask.
  • Violeds, the gift of light, is the worlds first technology that SETi and Seoul Viosys have developed and manufactured over 20 years with Seoul Semiconductors R&D investment.
  • So we expect that our air purifier (VAC) and surface disinfection device (VSM+) that will be launched help reduce the spread of viruses, said SETis representative.

Fibralign Announces Strategic Partnership With Terumo

Tuesday, June 2, 2020 - 11:00am

Fibralign is currently pursuing regulatory approval in the US, Europe and other key markets to market BioBridge for addressing lymphedema.

Key Points: 
  • Fibralign is currently pursuing regulatory approval in the US, Europe and other key markets to market BioBridge for addressing lymphedema.
  • This agreement is an outcome of an ongoing collaboration between Fibralign and Terumo where the two companies have agreed to partner in efforts to commercialize BioBridge in Japan.
  • Terumo has received exclusive distributor rights to BioBridge in Japan for treating and preventing lymphedema and has agreed to provide defined milestone payments to Fibralign.
  • Terumo is also taking the lead in conducting clinical studies and completing the regulatory review before introducing BioBridge commercially in Japan.

Asuragen to Present at 2020 European Society of Human Genetics (ESHG) Virtual Conference

Tuesday, June 2, 2020 - 8:00am

Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, will showcase its latest product developments via a live corporate satellite and scientific poster presentations at the upcoming European Human Genetics Virtual Conference ESHG 2020.2, running from June 6-9.

Key Points: 
  • Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, will showcase its latest product developments via a live corporate satellite and scientific poster presentations at the upcoming European Human Genetics Virtual Conference ESHG 2020.2, running from June 6-9.
  • The annual event moved to an online, virtual platform in response to the COVID-19 pandemic.
  • Video presentations of the Companys scientific posters will further highlight the latest product innovations within the growing AmplideX portfolio.
  • Asuragen is a molecular diagnostic product company changing the way patients are treated in genetics and oncology.

How Does a Company Protect Thousands of Employees Amidst a Pandemic?

Monday, June 1, 2020 - 9:32pm

As we prepare to re-open doors and conduct business once again, how can we protect employees and demonstrate compassion during these difficult times?

Key Points: 
  • As we prepare to re-open doors and conduct business once again, how can we protect employees and demonstrate compassion during these difficult times?
  • Employers could take months tracking down sources of personal protective equipment, and then ordering it, receiving it, and sorting it.
  • Then you risk the employees health by bringing them together to get everything.
  • Bluemark is playing a pivotal role in making sure business return to normalcy while promoting and supporting the safety of employees.